Cardiometabolic Health Congress (CMHC)
Avatar

58 y/o Male Treated for Hypertension, Gout, Type 2 Diabetes, and Hypercholesterolemia: What Are the Treatment Strategies for CV and Renal Risk Reduction? SLGT2 Inhibitors Efficacy Review

By Cardiometabolic Health Congress (CMHC) FEATURING George Bakris, Stephen D. Wiviott, Robert Eckel
By Cardiometabolic Health Congress (CMHC) FEATURING George Bakris, Stephen D. Wiviott, Robert Eckel
292 views
September 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
16:57
William White

Ambulatory Blood Pressure Monitoring

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
20:48
Michael Gallagher

Cardiac CT in 2023: From Anatomy to Physiology to Plaque Burden and …

49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
10:12
AHA 2022 Conference Coverage

AHA 2022: Chlorthalidone Compared to Hydrochlorothiazide for the Pre…

Feat. A. Ishani
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

27:14
MUSC Cardiology

Which Diuretic(s) Are Best in HF? Update Based on Recent Clinical Tr…

Feat. R. Mentz
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease